Oppenheimer Assumes NovoCure Ltd. (NVCR) at Outperform
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $12.23 --0%
Rating Summary:
9 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 1
Rating Summary:
9 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 1
Join SI Premium – FREE
Oppenheimer analyst Kevin DeGeeter assumes coverage on NovoCure Ltd. (NASDAQ: NVCR) with a Outperform rating.
For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.
Shares of NovoCure Ltd. closed at $67.43 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Range Resources (RRC) to Sector Perform
- Goldman Sachs Resumes Dada Nexus Ltd. (DADA) at Neutral
- Goldman Sachs Starts Victoria's Secret (VSCO) at Sell, 'Tough macro and ongoing competitive pressures'
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
